IronOak Wealth LLC. Makes New Investment in Intuitive Surgical, Inc. $ISRG

Key Points

• IronOak Wealth LLC has made a new investment in Intuitive Surgical, Inc., acquiring 2,022 shares valued at approximately $1,099,000 during the second quarter.
• Hedge funds have been increasing their stakes in Intuitive Surgical, with notable increases from firms like Chilton Capital Management (up by 614.3%) and Global Financial Private Client (up by 253.3%) in the first quarter.
• Insider trading activity included the sale of 45,224 shares by insiders, including a significant transaction by Gary S. Guthart, highlighting a 59.69% decrease in their ownership following the sale.

IronOak Wealth LLC. bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 2,022 shares of the medical equipment provider's stock, valued at approximately $1,099,000.

Other hedge funds have also made changes to their positions in the company. Chilton Capital Management LLC increased its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares in the last quarter. Global Financial Private Client LLC increased its holdings in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the last quarter. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the first quarter worth $26,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Intuitive Surgical in the first quarter valued at $30,000. Finally, TD Capital Management LLC boosted its holdings in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the transaction, the director directly owned 739 shares of the company's stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 in the last quarter. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $438.72 on Monday. The company has a market cap of $157.27 billion, a PE ratio of 61.19, a price-to-earnings-growth ratio of 4.60 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The firm has a 50-day moving average of $476.64 and a 200-day moving average of $503.43.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.78 EPS. Analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on ISRG. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Zacks Research lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Piper Sandler reissued an "overweight" rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Thirteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.